Investors & Media

SEC Filing Details

Investor Relations Menu
Investor Home
News & Events
Press Releases Events & Presentations
Stock Information
Stock Quote & Chart Historic Price Lookup Investment Calculator Analyst Coverage
Financials & Filings
SEC Filings
Corporate Governance
Documents & Charters Management Team Board of Directors Scientific Advisory Board Committee Composition
Investor Resources
Investor FAQs Investor Contact Email Alerts
Contact

Elizabeth Pingpank Hickin
Vice President, Investor Relations
ehickin@zentalis.com

Document Details

Form
424B5
Filing Date
Jun 15, 2023
Document Date
Jun 15, 2023
Form Description
Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3
Filing Group
Registration Statements
Company
Zentalis Pharmaceuticals
Issuer
ZENTALIS PHARMACEUTICALS, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS